BRPI0517950A - uso de andrógenos para reduzir a probabilidade de adquirir ou para o tratamento do envelhecimento da pele - Google Patents

uso de andrógenos para reduzir a probabilidade de adquirir ou para o tratamento do envelhecimento da pele

Info

Publication number
BRPI0517950A
BRPI0517950A BRPI0517950-5A BRPI0517950A BRPI0517950A BR PI0517950 A BRPI0517950 A BR PI0517950A BR PI0517950 A BRPI0517950 A BR PI0517950A BR PI0517950 A BRPI0517950 A BR PI0517950A
Authority
BR
Brazil
Prior art keywords
acquiring
loss
androgens
likelihood
reduce
Prior art date
Application number
BRPI0517950-5A
Other languages
English (en)
Inventor
Mohamed El-Alfy
Fernand Labrie
Lamia Azzi
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorech Inc filed Critical Endorech Inc
Publication of BRPI0517950A publication Critical patent/BRPI0517950A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

USO DE ANDRóGENOS PARA REDUZIR A PROBABILIDADE DE ADQUIRIR OU PARA O TRATAMENTO DO ENVELHECIMENTO DA PELE. São revelados métodos inéditos de tratamento ou redução da probabilidade de adquirir doenças cutâneas causadas por deficiência de androgênio relacionada à idade, particularmente atrofia cutânea, perda de colágeno, perda de fibras elásticas, perda de tecido conjuntivo, celulite, e formação de rugas, em animais de sangue quente suscetíveis, incluindo seres humanos, que envolvem a administração de um androgênio e/ou um precursor esteróide sexual. Também são reveladas composições farmacêuticas para liberação do(s) ingrediente(s) ativo(s) úteis para a invenção.
BRPI0517950-5A 2004-11-01 2005-10-31 uso de andrógenos para reduzir a probabilidade de adquirir ou para o tratamento do envelhecimento da pele BRPI0517950A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Publications (1)

Publication Number Publication Date
BRPI0517950A true BRPI0517950A (pt) 2008-10-21

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517950-5A BRPI0517950A (pt) 2004-11-01 2005-10-31 uso de andrógenos para reduzir a probabilidade de adquirir ou para o tratamento do envelhecimento da pele

Country Status (20)

Country Link
US (1) US20060178352A1 (pt)
EP (1) EP1807062A4 (pt)
JP (1) JP2008517952A (pt)
KR (1) KR20070073964A (pt)
CN (1) CN101094676A (pt)
AP (1) AP2007003982A0 (pt)
AU (1) AU2005301035A1 (pt)
BR (1) BRPI0517950A (pt)
CA (1) CA2585666A1 (pt)
EA (1) EA200700983A1 (pt)
GE (1) GEP20094833B (pt)
HR (1) HRP20070183A2 (pt)
IL (1) IL182844A0 (pt)
MA (1) MA29220B1 (pt)
MX (1) MX2007005098A (pt)
NO (1) NO20072642L (pt)
RS (1) RS20070185A (pt)
TN (1) TNSN07163A1 (pt)
WO (1) WO2006047859A1 (pt)
ZA (1) ZA200703531B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835413B2 (en) 2004-10-20 2014-09-16 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8269380B2 (en) 2006-06-01 2012-09-18 Panasonic Corporation Brushless motor for washing machine having stress reduction on sensor casing and washing machine having the brushless motor mounted therein
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
US10076483B2 (en) * 2013-10-15 2018-09-18 Chelac Holding Gmbh Steroid carboxylic acid esters, compositions containing steroid carboxylic acid esters, and use of said compositions in local topical applications for cosmetic or dermatological purposes
RU2699674C1 (ru) * 2015-09-30 2019-09-09 Фуджифилм Корпорэйшн Композиция для чрескожной абсорбции
CN114728013A (zh) * 2019-09-23 2022-07-08 斯坦福大学托管董事会 延长妊娠以及月经或妊娠的并发症的治疗方法
US12426782B2 (en) 2020-11-06 2025-09-30 The Board Of Trustees Of The Leland Stanford Junior University Systems and temporal alignment methods for evaluation of gestational age and time to delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL190146A (pt) * 1953-08-26
SK286051B6 (sk) * 1993-01-19 2008-02-05 Endorecherche Inc. Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
MXPA00012304A (es) * 1998-06-11 2003-05-15 Endorech Inc Composiciones farmaceuticas y usos para el androst-5-ene-3beta, 17 beta-diol.
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
MX2007005098A (es) 2008-01-16
CN101094676A (zh) 2007-12-26
WO2006047859A1 (en) 2006-05-11
EP1807062A4 (en) 2009-06-03
IL182844A0 (en) 2007-09-20
HRP20070183A2 (en) 2007-08-31
MA29220B1 (fr) 2008-02-01
GEP20094833B (en) 2009-11-25
CA2585666A1 (en) 2006-05-11
US20060178352A1 (en) 2006-08-10
JP2008517952A (ja) 2008-05-29
TNSN07163A1 (en) 2008-11-21
KR20070073964A (ko) 2007-07-10
EA200700983A1 (ru) 2008-04-28
AU2005301035A1 (en) 2006-05-11
ZA200703531B (en) 2008-07-30
AP2007003982A0 (en) 2007-06-30
EP1807062A1 (en) 2007-07-18
RS20070185A (sr) 2008-09-29
NO20072642L (no) 2007-07-30

Similar Documents

Publication Publication Date Title
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
CY1125968T1 (el) Συσκευη και συστημα υποβοηθησης της καρδιας
WO2007089454A3 (en) Methods for enhancing skin treatments
CY1118059T1 (el) Συνθεσεις αντιλοιμωδων βασει λιπιδιων για αγωγη πνευμονικων λοιμωξεων
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BRPI0511235A (pt) preparado tópico e método para a administração transdérmica e localização de agentes terapêuticos
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
BRPI0416796A (pt) compostos orgánicos
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BRPI0408153A (pt) formulações para administração transdérmica ou transmucosa de agente ativo, métodos de tratamento de distúrbios hormonais em indivìduo, uso de formulação e de melhorador de permeação e kit para tratamento de indivìduo
WO2010036947A3 (en) Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
BRPI0507279A (pt) método e dispositivo para o tratamento do canal da teta de um animal
BR0212898A (pt) Método de tratamento de infecções do ouvido médio
WO2006073786A3 (en) Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
TNSN07163A1 (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
EA200702204A1 (ru) Лечение заболеваний соединительной ткани кожи
WO2003011327A3 (en) Secretin for the treatment of asthma
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
BRPI0415756A (pt) lipólise medicamentosa local, dirigida
WO2019010301A8 (en) Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap)
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
IL146132A0 (en) Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments
MX2012000503A (es) Metodo quimico para esterilizacion sexual y eliminacion de libido en mamiferos machos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.